22 results
8-K
EX-10.2
BDTX
Black Diamond Therapeutics Inc
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
that (a) relate to the business of the Company or its subsidiaries or other affiliates or any customer of, supplier to or business partner of the Company
DEF 14A
BDTX
Black Diamond Therapeutics Inc
27 Apr 21
Definitive proxy
4:06pm
concern anonymously or confidentially by postal mail. You may also indicate whether you are a stockholder, customer, supplier or other interested party
10-Q
32p78h
12 May 20
Quarterly report
7:34am
10-K
r4k6xes9dwe hpvlrm
24 Mar 20
Annual report
7:47am
424B4
l7zwif7qtbp0
30 Jan 20
Prospectus supplement with pricing info
4:43pm
S-1/A
zfco1eym7uoug zonwj1
21 Jan 20
IPO registration (amended)
8:24am
S-1/A
EX-1.1
gtgra n4a
21 Jan 20
IPO registration (amended)
8:24am
S-1
2popv3 qc
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.7
covret 50w0i
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.10
xono2kb7orhq4mas0qu
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.9
dtw806y
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.8
5bdfuoio81uuk4wmx
3 Jan 20
IPO registration
3:23pm
DRS/A
4bpmb6b0c4
13 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
u49t057s
30 Oct 19
Draft registration statement (amended)
12:00am